Resistin is a prognostic factor in type 2 diabetes.

ConclusionsHigher resistin is associated with reduced survival in T2D, irrespectively of TNF ‐α. Resistin concentration of above 11 ng/mL indicates T2D patients at an increased risk of unfavorable outcomes. Leptin was not a prognostic factor. These results suggest that in T2D, association of resistin with unfavorable outcomes might, at least in part, result from its pro‐inflammatory pr operties.

Source: Diabetes/Metabolism Research and Reviews - November 16, 2018 Category: Endocrinology Authors: Agnieszka Kap łon‐Cieślicka, Agata Tymińska, Marek Rosiak, Krzysztof Ozierański, Michał Peller, Ceren Eyileten, Agnieszka Kondracka, Justyna Pordzik, Dagmara Mirowska‐Guzel, Grzegorz Opolski, Marek Postuła, Krzysztof J. Filipiak Tags: RESEARCH ARTICLE Source Type: research